Dipeptidyl Peptidase IV Inhibitors for Management of Type 2 Diabetes

By Jagatkumar Upadhyay

This book provides detailed summary about Dipeptidyl Peptidase IV (DPP IV) Inhibitors in Management of Type 2 Diabetes. DPP IV inhibitors are established therapy for managing blood glucose in patients with type 2 diabetes. Several DPP IV inhibitors are developed in last few years and are used clinically all over the world. This book describes role of Glucagon Like Peptide-1 (GLP-1), an incretin hormone in insulin secretion and how DPP IV inhibitors affect action of GLP-1. It is followed by chemistry of DPP IV inhibitors and their lead optimization strategies for clinical development.

• Format: Paperback
• Language: English
• ISBN: 6205508532
• ISBN13: 9786205508534
• Release Date: October 2022
• Publisher: LAP Lambert Academic Publishing
• Length: 84 Pages
• Weight: 0.30 lbs.
• Dimensions: 0.2" x 6.0" x 9.0"